Floxuridine Injection, Powder, Lyophilized, For Solution
Product Images NDC 81643-9270

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Floxuridine (NDC 81643-9270). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jnd Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Floxuridine For Injection Usp 1)

Chemical structure of Floxuridine showing its molecular arrangement with fluorine, nitrogen, oxygen, carbon, and hydrogen atoms in a distinct ring and sugar moiety configuration.*

FDA Label Image

Floxuridine Cerona (Floxuridine For Injection Usp 2)

Label for Floxuridine injection, USP, 500 mg per vial for intra-arterial use only. The label indicates a 5 mL vial and includes storage instructions for the powder and reconstituted solution. Distributed by Cerona Therapeutics, Wellesley, MA.*

FDA Label Image

Representative Carton Serialization Image (Floxuridine For Injection Usp 3)

Label image showing a drug identification barcode with corresponding text fields including lot number, expiration date (MMYYYY format), GTIN (00301234567896), and serial number (12345678901234). The layout is in black and white with fixed spacing, suitable for scanning and tracking purposes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.